AURINIA PHARMACEUTICALS
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis, focal segmental glomerulosclerosis, and Dry Eye Syndrome.
AURINIA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2011-01-01
Address:
Victoria, British Columbia, Canada
Country:
Canada
Website Url:
http://www.auriniapharma.com
Total Employee:
251+
Status:
Active
Contact:
+1 (250) 744-2487
Email Addresses:
[email protected]
Total Funding:
658.46 M USD
Technology used in webpage:
Nginx JsDelivr Common Name Invalid Amazon S3 Ruby On Rails Token OSS CDN GoDaddy SSL Squarespace Hosted CenturyLink
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Innate Biologics
Innate Biologics offers tissue-targeted anti-inflammatory treatment to patients suffering from conditions and diseases.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Vividion Therapeutics
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2013-02-05 | Isotechnika Pharma | Isotechnika Pharma acquired by Aurinia Pharmaceuticals | N/A |
Investors List
Apple Tree Partners
Apple Tree Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - Aurinia Pharmaceuticals
Redmile Group
Redmile Group investment in Post-IPO Equity - Aurinia Pharmaceuticals
ILJIN Life Science
ILJIN Life Science investment in Post-IPO Equity - Aurinia Pharmaceuticals
Difference Capital
Difference Capital investment in Post-IPO Equity - Aurinia Pharmaceuticals
Great Point Partners
Great Point Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Aurinia Pharmaceuticals
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Aurinia Pharmaceuticals
venBio Partners
venBio Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - Aurinia Pharmaceuticals
Official Site Inspections
http://www.auriniapharma.com Semrush global rank: 3.26 M Semrush visits lastest month: 4.43 K
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aurinia Pharmaceuticals"
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high …See details»
Aurinia Pharmaceuticals Inc. | LinkedIn
Aurinia Pharmaceuticals Inc. | 27,020 followers on LinkedIn. Aurinia is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high …See details»
Aurinia Pharmaceuticals - Org Chart, Teams, Culture & Jobs | The …
View Aurinia Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Aurinia Pharmaceuticals (AUPH) Company Profile
Jan 26, 1999 Company profile for Aurinia Pharmaceuticals Inc. (AUPH) stock, with a description, list of executives, contact details and other key facts.See details»
Aurinia Pharmaceuticals - 2025 Company Profile & Team - Tracxn
Aug 2, 2025 Aurinia Pharmaceuticals is a public company based in Edmonton (Canada), founded in 1993. It operates as a Developer of therapeutics for autoimmune diseases. Aurinia …See details»
Aurinia Pharmaceuticals - Crunchbase Company Profile …
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient …See details»
Management Team | Aurinia Pharmaceuticals Inc. (AUPH)
Meet the experienced management team driving innovation and growth at Aurinia Pharmaceuticals Inc. (AUPH).See details»
Aurinia Pharmaceuticals - Craft
Oct 29, 2024 Aurinia is a biopharmaceutical company focused on developing and commercializing therapeutic products. It develops voclosporin, an investigational drug, for the …See details»
Alberta Tech Ecosystem | Aurinia Pharmaceuticals company …
Aurinia Pharmaceuticals, late-stage biopharma developing therapies for serious diseases, including voclosporin for lupus nephritis, proteinuric diseases, and dry eye syndrome. Here …See details»
Aurinia Pharmaceuticals
Jun 17, 2025 Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet …See details»
Our Company | Aurinia Pharmaceuticals Inc. (AUPH)
In January 2021, Aurinia introduced LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. Aurinia is also developing …See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 26, 2024 View Aurinia Pharmaceuticals (www.auriniapharma.com) location in Alberta, Canada , revenue, industry and description. Find related and similar companies as well as …See details»
Aurinia Pharmaceuticals Inc. - LinkedIn
Aurinia Pharmaceuticals Inc. | 27,020 followers on LinkedIn. Aurinia is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high …See details»
Aurinia Pharmaceuticals Inc. - Executive Bio, Top Executies, and ...
Before Cerecor, he was the Vice President of Finance at Sucampo Pharmaceuticals, Inc., where he was responsible for building out the finance organization to effectively support the …See details»
Aurinia Appoints Joe Miller as Chief Financial Officer
VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical …See details»
Investors - Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the …See details»
Contact Us | Aurinia Pharmaceuticals Inc. (AUPH)
To report a suspected adverse event (AE) or product quality complaint (PQC), please submit online at https://auriniapharma.public.reportum.com or by calling Aurinia Pharmaceuticals call …See details»
Aurinia Pharmaceuticals Company Profile | Management and
Aurinia Pharmaceuticals Profile and History Aurinia Pharmaceuticals a clinical-stage biopharmaceutical company develops and commercializes therapies to treat various diseases …See details»
Aurinia Pharmaceuticals Inc - Company Profile - GlobalData
Up-to-date Aurinia Pharmaceuticals Inc company overview including funding information, company profile, key statistics, peer comparison and more.See details»
Aurinia Reports Fourth Quarter and Full Year 2020 Financial …
The primary driver for the decrease of $2.5 million in R&D spend in 2020 was a decrease in drug manufacturing and supply costs, lower Contract Research Organization (CRO) expenses and …See details»